Published on in Vol 9, No 7 (2020): July
![Gaining First Insights on Secondary Progressive Multiple Sclerosis Patients Treated With Siponimod in Clinical Routine: Protocol of the Noninterventional Study AMASIA Gaining First Insights on Secondary Progressive Multiple Sclerosis Patients Treated With Siponimod in Clinical Routine: Protocol of the Noninterventional Study AMASIA](https://asset.jmir.pub/assets/7f48b7d39cd69ea26eb47a858a082188.png 480w,https://asset.jmir.pub/assets/7f48b7d39cd69ea26eb47a858a082188.png 960w,https://asset.jmir.pub/assets/7f48b7d39cd69ea26eb47a858a082188.png 1920w,https://asset.jmir.pub/assets/7f48b7d39cd69ea26eb47a858a082188.png 2500w)
1 Department of Neurology, Center of Clinical Neuroscience, Carl Gustav Carus University Clinic, University Hospital of Dresden, Dresden, Germany
2 Department of Neurology, St Josefs-Krankenhaus, Potsdam, Germany
3 Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany
4 Neurological Practice Center, NTD & Neuropoint Academy, Ulm, Germany
5 Institute of Neuropathology, University Medical Center Goettingen, Goettingen, Germany
6 Department of Neurology, University Medical Center Goettingen, Goettingen, Germany
7 Novartis Pharma GmbH, Nuremberg, Germany